Each of the Testisin mRNA expressing Tera-2 clones (C1, C11, C29 and C33) demonstrated reduced tumour burden relative to the parental and vector only lines, and visibly displaced less of the testis causing fewer disruptions to the blood supply. Here, PRSS21 is linked to neoplasm.